IQVIA Appoints Executive Vice President and CFO

| < 1 minute read

Reading Time: < 1 minute

IQVIA Holdings Inc. a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Ron Bruehlman as Executive Vice President and interim Chief Financial Officer, succeeding Mike McDonnell who is leaving the company to become Chief Financial Officer (CFO) of Biogen Inc.

Ron was previously the Chief Financial Officer of IMS Health from 2011 until the merger of IMS Health and Quintiles in 2016. Since the merger, Ron has continued to play an active role in the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib, Chairman and CEO of IQVIA.  In a statement, he said, “I am thrilled Ron has agreed to serve as our interim CFO. I have known and worked continuously with Ron for nearly 25 years. Ron is a world-class CFO with outstanding strategic and operational skills, a deep knowledge of our company and industry, as well as extensive experience in leading large global finance organizations,” said Ari Bousbib, Chairman and CEO of IQVIA. Bousbib added, “Ron is widely respected and admired across IQVIA and will assume this role seamlessly. I want to thank Mike for his contributions to IQVIA and wish him well in his new role.”

“I am excited to continue serving the company as we navigate through the COVID-19 situation, execute the strategy that we first envisioned at the time of the merger, and drive towards the achievement of our Vision 22 goals,” said Mr. Bruehlman.

Posted in

About the author

Related Posts